Bristol-Myers Squibb Company (BMY) stock news · P/E 13, rev $48.19B
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Christopher S. Boerner Ph.D..
This BMY news page leads with what Bristol-Myers Squibb Company filed — not a scraped headline mill.
No cached 8-K sentence for BMY yet. We will not pad this page with generic market recap.
Latest reported BMY revenue for 2025-12-31 was $48.19B. Net income was $7.05B. Revenue was down 0.2% from 2024-12-31 to 2025-12-31. BMY currently screens at market cap $95.36B and trailing P/E 13.2.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the BMY stock page; for the tape open the quote page.
BMY stock news FAQ
What are BMY's latest revenue and net income?
Latest cached Bristol-Myers Squibb Company (BMY) revenue for Dec 31, 2025 was $48.19B. Net income was $7.05B. Statements: https://lician.com/financials/bmy
How did BMY revenue change from the prior cached period?
Cached Bristol-Myers Squibb Company (BMY) revenue was down 0.2% from $48.30B (Dec 31, 2024) to $48.19B (Dec 31, 2025). Statements: https://lician.com/financials/bmy
What is BMY's P/E ratio?
Bristol-Myers Squibb Company (BMY) trailing P/E is 13.2 on the latest cached fundamentals snapshot.
What is BMY's market cap?
Bristol-Myers Squibb Company (BMY) market cap is $95.36B on the latest cached fundamentals snapshot.
What kind of company is BMY?
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US.
Where is BMY stock news listed?
Cached stock news for Bristol-Myers Squibb Company (BMY) is listed at https://lician.com/news/bmy. Filings: https://lician.com/sec/bmy
Not investment advice.